Innoveren Scientific Inc. (IVRN)

Market Cap	3.20K +99.9%
Revenue (ttm)	n/a -71.9%
Net Income	-3.26M
EPS	-5.51
Shares Out	8.01M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	700
Open	0.0004
Previous Close	0.0002
Day's Range	0.0004 - 0.0004
52-Week Range	0.000001 - 0.0007
Beta	471.79
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Innoveren Scientific

Innoveren Scientific Inc., a medical bioscience company that develops technology in regenerative medicine for limb salvage. It is also developing immunotherapies for ovarian cancer, pancreatic cancer, and mesothelioma. The company was formerly known as H-CYTE, Inc. and changed its name to Innoveren Scientific Inc. in July 2023. The company is headquartered in Tampa, Florida.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Michael Yurkowsky
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: IVRN

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 1, 2026

Data Sources Report a data error